Oregon Public Employees Retirement Fund Nektar Therapeutics Transaction History

Oregon Public Employees Retirement Fund

$4.78 Billion
Q1 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	SELL	$0.64 - $3.15 $102 - $504	-160 Reduced 0.26%	62,357 $43,000
Q4 2022 Jan 26, 2023	BUY	$2.03 - $4.28 $2,567 - $5,414	1,265 Added 2.07%	62,517 $0
Q3 2022 Nov 01, 2022	BUY	$3.04 - $5.14 $422 - $714	139 Added 0.23%	61,252 $196,000
Q2 2022 Jul 25, 2022	SELL	$3.17 - $6.17 $26,945 - $52,445	-8,500 Reduced 12.21%	61,113 $232,000
Q1 2022 Apr 21, 2022	BUY	$4.16 - $13.72 $39,990 - $131,890	9,613 Added 16.02%	69,613 $375,000

Q4 2021 Feb 01, 2022	SELL	$10.83 - $18.41 $14,588 - $24,798	-1,347 Reduced 2.2%	60,000 $811,000
Q3 2021 Oct 19, 2021	SELL	$13.07 - $18.84 $10,573 - $15,241	-809 Reduced 1.3%	61,347 $1.1 Million
Q2 2021 Jul 23, 2021	BUY	$16.52 - $20.4 $48,188 - $59,506	2,917 Added 4.92%	62,156 $1.07 Million
Q4 2020 Feb 09, 2021	SELL	$15.77 - $19.03 $17,898 - $21,599	-1,135 Reduced 1.88%	59,239 $1.01 Million
Q3 2020 Nov 03, 2020	SELL	$16.59 - $24.79 $83,530 - $124,817	-5,035 Reduced 7.7%	60,374 $1 Million
Q2 2020 Jul 21, 2020	SELL	$16.86 - $23.44 $6,963 - $9,680	-413 Reduced 0.63%	65,409 $1.52 Million
Q1 2020 Apr 20, 2020	SELL	$14.47 - $27.96 $7,032 - $13,588	-486 Reduced 0.73%	65,822 $1.18 Million
Q4 2019 Feb 05, 2020	BUY	$15.87 - $23.12 $772,297 - $1.13 Million	48,664 Added 275.81%	66,308 $1.43 Million
Q3 2019 Nov 07, 2019	SELL	$16.91 - $36.27 $10,433 - $22,378	-617 Reduced 3.38%	17,644 $321,000
Q2 2019 Jul 16, 2019	BUY	$31.0 - $36.3 $3,348 - $3,920	108 Added 0.59%	18,261 $650,000
Q1 2019 May 07, 2019	SELL	$31.58 - $46.35 $155,089 - $227,624	-4,911 Reduced 21.29%	18,153 $610,000
Q4 2018 Feb 07, 2019	SELL	$30.43 - $56.65 $22.4 Million - $41.6 Million	-735,050 Reduced 96.96%	23,064 $758,000
Q4 2018 Feb 05, 2019	BUY	$30.43 - $56.65 $21.2 Million - $39.5 Million	697,625 Added 1153.31%	758,114 $23,000
Q3 2018 Oct 30, 2018	BUY	$46.46 - $68.49 $19,931 - $29,382	429 Added 0.71%	60,489 $3.69 Million
Q2 2018 Aug 13, 2018	BUY	$46.25 - $104.45 $2.78 Million - $6.27 Million	60,060 New	60,060 $2.93 Million

Others Institutions Holding NKTR

# of Institutions

128

Shares Held

111M

Call Options Held

150K

Put Options Held

Deep Track Capital, LP Greenwich, CT

18.4M
Shares

$21.5 Million
0.57% of portfolio
Vanguard Group Inc Valley Forge, PA

12M
Shares

$14.1 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

7.57M
Shares

$8.86 Million
0.02% of portfolio
Primecap Management CO Pasadena, CA

6.97M
Shares

$8.15 Million
0.0% of portfolio
Black Rock Inc. New York, NY

5.88M
Shares

$6.88 Million
0.0% of portfolio

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $219M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oregon Public Employees Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on Oregon Public Employees Retirement Fund with notifications on news.

Account